Loading clinical trials...
Loading clinical trials...
The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used as a marker of severe sepsis (including septic shock) in patients presenting to the emergency department wi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Axis Shield Diagnostics Ltd
NCT06854640 · Sepsis, Coagulopathy
NCT07460349 · Early Onset Sepsis
NCT04886284 · Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, and more
NCT07084129 · Sepsis
NCT06517810 · Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Cooper University Hospital
Camden, New Jersey
Universitetssjukhuset i Linkoping
Linköping
Skanes Universitetssjukhus i Lund
Lund
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions